OIPN | Tools | References |
---|---|---|
Current tools used for the clinical diagnosis of OIPN | National Cancer Institute-Common Toxicity Criteria (NCI-CTC) | [23] |
Total Neuropathy Score clinical version (TNSc) | [24] | |
Modified Inflammatory Neuropathy Cause and Treatment (INCAT) group sensory sum score (mISS) | [25] | |
European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 | [27] | |
CIPN (chemotherapy induced peripheral neuropathy) 20 quality-of-life measures | [26] | |
Skin biopsy and quantified intraepidermal nerve fiber density | ||
LDI technology | [22] | |
Surface electromyography recording | [30] | |
Comments for the ideal CIPN assessment tools | Specific to CIPN; validated in different types of chemotherapy; easy for patients to understand and complete; can be used in postal questionnaires as well as face to face; performs consistently in different settings; requires minimal training in use and scoring; sensitive to change; detects CIPN early; and reliable with minimal interrater variability | [2] |